United States: FDA's Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee On Health To Hold Hearing On Regulation Of Diagnostic Tests - Goodwin Procter LLP

On March 1, 2024, the Office of Information and Regulatory Affairs ("OIRA"), Office of Management and Budget ("OMB"), Executive Office of the President received the final version of FDA's...